P53-dependent radiosensitizing effects of Hsp90 inhibitor 17-Allylamino-17-demethoxygeldanamycin on human oral squamous cell carcinoma cell lines
Satoru Shintani(Komatsu (Japan)), Hiroyuki Hamakawa(Ehime University)
Cited by 35
Related Papers
Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer
|International Journal of Cancer|2003|95
Potential anti-osteoporotic effects of herbal extracts on osteoclasts, osteoblasts and chondrocytes in vitro
|BMC Complementary and Alternative Medicine|2014|26